Administration of G-CSF after autologous peripheral stem cell transplantation is clinical and cost-effective

被引：0
|
作者：
Fruchart, C [1 ]
Journet, V [1 ]
Damourette, S [1 ]
Rivière, A [1 ]
German, O [1 ]
Musafiri, D [1 ]
Peny, AM [1 ]
机构：
[1] Ctr Francois Baclesse, F-14021 Caen, France
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [41] Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation
    P Cetkovský
    V Koza
    P Jindra
    P Škopek
    M Švojgrová
    Bone Marrow Transplantation, 1997, 20 : 639 - 641
  • [42] Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation
    Cetkovsky, P
    Koza, V
    Jindra, P
    Skopek, P
    Svojgrova, M
    BONE MARROW TRANSPLANTATION, 1997, 20 (08) : 639 - 641
  • [43] Kinetics of hemopoietic recovery after peripheral blood stem cell transplantation:: Impact of stem cell purification and G-CSF
    Piccirillo, N
    Sorà, F
    Laurenti, L
    Chiusolo, P
    Serafini, R
    Cicconi, S
    Leone, G
    Sica, S
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (01) : 7 - 14
  • [44] A randomized study of filgrastim (G-CSF) after autologous peripheral blood transplantation.
    Ojeda, E
    Garcia-Bustos, J
    Aguado, MJ
    Arrieta, R
    Quevedo, E
    Jiménez-Yuste, V
    Martin, MP
    Canales, M
    Hdez-Maraver, MD
    Jiménez, M
    Alvarez, MT
    Morado, M
    Sevilla, J
    Hdez-Navarro, F
    BLOOD, 1998, 92 (10) : 325B - 325B
  • [45] Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
    DiPersio, John F.
    Stadtmauer, Edward A.
    Nademanee, Auayporn
    Micallef, Ivana N. M.
    Stiff, Patrick J.
    Kaufman, Jonathan L.
    Maziarz, Richard T.
    Hosing, Chitra
    Frueehauf, Stefan
    Horwitz, Mitchell
    Cooper, Dennis
    Bridger, Gary
    Calandra, Gary
    BLOOD, 2009, 113 (23) : 5720 - 5726
  • [46] Use of G-CSF after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
    Maisano, Valerio
    Devillier, Raynier
    Furst, Sabine
    Legrand, Faezeh
    Harbi, Samia
    Faucher, Catherine
    Chabannon, Christian
    Granata, Angela
    Weiller, Pierre Jean
    Blaise, Didier
    BLOOD, 2017, 130
  • [47] Peg-Filgrastim after autologous peripheral blood stem cell transplantation:: a matched-pair analysis and kinetics of G-CSF
    Piccirillo, N
    De Matteis, S
    Laurenti, L
    Chiusolo, P
    De Vita, S
    Sorà, F
    Putzulu, R
    Reddiconto, G
    Farina, G
    d'Onofrio, G
    Leone, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S102 - S102
  • [48] REVISITING THE UTILITY OF G-CSF POST-AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Portuguese, Andrew
    Hill, Geoffrey
    Holmberg, Leona
    Lee, Stephanie
    Green, Damian
    Mielcarek, Marco
    Yeh, Albert
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 482 - 483
  • [49] Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment
    Stakiw, Julie
    Sabry, Waleed
    Elemary, Mohamed
    Bosch, Mark J.
    Danyluk, Pat
    Aggarwal, Vibhuti
    Mondal, Prosanta
    BLOOD, 2018, 132
  • [50] Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration
    Ali, Naveed
    Cooper, Brenda
    Tomlinson, Benjamin
    Metheny, Leland
    Caimi, Paolo
    Boughan, Kirsten
    Gallogly, Molly
    Otegbeye, Folashade
    Malek, Ehsan
    Lazarus, Hillard
    Creger, Richard
    de Lima, Marcos
    BONE MARROW TRANSPLANTATION, 2020, 55 (08) : 1697 - 1700
12345